4//SEC Filing
ORDONEZ KATHY 4
Accession 0001299130-21-000070
CIK 0001299130other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 9:52 PM ET
Size
31.0 KB
Accession
0001299130-21-000070
Insider Transaction Report
Form 4
ORDONEZ KATHY
Director
Transactions
- Exercise/Conversion
Common Stock
2021-02-16$6.98/sh+35,000$244,300→ 91,767 total - Exercise/Conversion
Common Stock
2021-02-16$5.79/sh+25,000$144,750→ 116,767 total - Exercise/Conversion
Common Stock
2021-02-16$8.98/sh+25,000$224,500→ 141,767 total - Exercise/Conversion
Common Stock
2021-02-16$3.81/sh+25,000$95,250→ 166,767 total - Exercise/Conversion
Common Stock
2021-02-16$2.90/sh+25,485$73,907→ 192,252 total - Exercise/Conversion
Common Stock
2021-02-16$2.63/sh+50,394$132,536→ 242,646 total - Sale
Common Stock
2021-02-16$47.58/sh−118,667$5,646,651→ 123,979 total - Sale
Common Stock
2021-02-16$48.47/sh−101,004$4,895,260→ 22,975 total - Exercise/Conversion
Stock Option (right to buy)
2021-02-16−35,000→ 0 totalExercise: $6.98Exp: 2024-12-17→ Common Stock (35,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-02-16−25,000→ 0 totalExercise: $3.81Exp: 2027-05-24→ Common Stock (25,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-02-16−50,394→ 37,106 totalExercise: $2.63From: 2018-03-15Exp: 2028-03-15→ Common Stock (50,394 underlying) - Sale
Common Stock
2021-02-16$49.00/sh−1,100$53,900→ 21,875 total - Exercise/Conversion
Stock Option (right to buy)
2021-02-16−25,000→ 0 totalExercise: $5.79Exp: 2025-05-20→ Common Stock (25,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-02-16−25,000→ 0 totalExercise: $8.98Exp: 2026-05-17→ Common Stock (25,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-02-16−25,485→ 324,515 totalExercise: $2.90From: 2017-12-15Exp: 2027-11-15→ Common Stock (25,485 underlying)
Footnotes (4)
- [F1]This sale price represents the weighted average sale price of the shares sold ranging from $47.00 to $47.99 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4
- [F2]This sale price represents the weighted average sale price of the shares sold ranging from $48.00 to $48.98 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4
- [F3]The shares subject to the option are fully vested and exercisable
- [F4]The shares subject to the option vest in equal monthly installment, over a four year period
Documents
Issuer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
CIK 0001299130
Entity typeother
Related Parties
1- filerCIK 0001222643
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 9:52 PM ET
- Size
- 31.0 KB